Fundacio Institut D Investigacio Biomedica De Bellvitge Idibell
L'Hospitalet de Llobregat, CT
- UEI
- T24CKEMW3Q93
- CAGE
- 646DB
- Primary NAICS
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Other
- Corporate family
-
-
- MXS8JR1F8YL6
-
- SAM.gov registration date
- Physical address
- Avinguda de la Granvia de l’Hospitalet, 199, 08908 L'Hospitalet de Llobregat, Barcelona, Spain
- Website
- idibell.cat
- Founded
- 2004
- Employees
- 251-1K
- Estimated annual revenue
- $100M-$250M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 87 Engineering & Management Services
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
Grant subawards
| Prime recipient | Prime award | Amount | Awarded |
|---|---|---|---|
| Beckman Research Institute Of The City Of Hope | R01CA263318 | $29,678 | |
| The Trustees Of Columbia University In The City Of New York | R01HD108467 | $43,200 | |
| Northwestern University | R01AG086270 | $83,767 | |
| The Trustees Of Columbia University In The City Of New York | R01HD108467 | $61,920 |
Similar vendors
About the company
Fundacio Institut D Investigacio Biomedica De Bellvitge Idibell (Idibell) is a medical research center focused on cancer, neuroscience, and translational medicine located in Spain. Idibell conducts basic research to address clinically relevant questions.
As a prime recipient, Idibell has received an Army Medical Command project grant for $801,755 to investigate the role of cancer cell chromatin remodeling on immune cell interactions in the tumor microenvironment. The 3-year project running through 2025 is funded via the Military Medical Research and Development program.
Idibell has also worked as a subrecipient on cancer, rare disease, and mental health research projects. As a subcontractor, Idibell has provided human biosamples, genomic data, biostatistics support, and bioinformatics analyses to prime recipients including Beckman Research Institute of the City of Hope, Icahn School of Medicine at Mount Sinai, SUNY Downstate Medical Center, Fred Hutchinson Cancer Center, and Cedars-Sinai Medical Center. Specific federal grant programs Idibell has supported as a subrecipient include an NIH R01 studying Lynch Syndrome, an NIH research project on post-COVID inflammatory conditions in children, and a study of gene-environment interactions in colorectal cancer funded by the NCI.
Quick answers
Is Fundacio Institut D Investigacio Biomedica De Bellvitge Idibell registered in SAM.gov?
Yes. Fundacio Institut D Investigacio Biomedica De Bellvitge Idibell's SAM.gov registration is active through December 31, 2026.
What is Fundacio Institut D Investigacio Biomedica De Bellvitge Idibell's CAGE code?
Fundacio Institut D Investigacio Biomedica De Bellvitge Idibell's CAGE code is 646DB, and its Unique Entity ID (UEI) is T24CKEMW3Q93.
What is Fundacio Institut D Investigacio Biomedica De Bellvitge Idibell's most recent federal award?
Fundacio Institut D Investigacio Biomedica De Bellvitge Idibell's most recent federal grant award is Dissecting the role of cancer cell chromatin remodeling on the landscape of tumor immune microenvironment (W81XWH2210960), from Defense Health Agency, on September 30, 2022.
On GovTribe
See Fundacio Institut D Investigacio Biomedica De Bellvitge Idibell's full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors